Physician profile
Cara A Morris
NPI 1861427841
$1,448.28
in general payments reported to CMS, 2019-2025
11 companies · $72.85 in 2025
The $72.85 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2021: $172 · 2022: $244 · 2023: $466 · 2024: $312 · 2025: $72.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $851.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $498.85 | 2022-2025 | Acuvue |
| Alcon Vision LLC | $438.37 | 2021-2024 | Total30, Dailies Total1, Precision 1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $114.99 | 2019 | |
| Bausch & Lomb Americas INC. | $107.12 | 2024 | Infuse |
| Rxsight INC | $80.00 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Regeneron Healthcare Solutions, INC. | $66.28 | 2019 | |
| Coopervision INC. | $54.23 | 2022-2025 | Clariti Contact Lens |
| Kala Pharmaceuticals, INC. | $39.37 | 2022 | |
| Biotissue Holdings INC. | $21.89 | 2025 | |
| Dompe US, INC. | $13.77 | 2022 | |
| Abbvie INC. | $13.41 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cara Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.